Infliximab-related hepatitis: discussion of a case and review of the literature.

Internal and Emergency Medicine
Stefano ManciniLuca Roncucci

Abstract

Despite its rarity, infliximab-related hepatitis constitutes a cutting edge and challenging problem. In December 2004, a drug warning was issued by the Food and Drug Administration to alert healthcare professionals to the risk of hepatotoxicity in course of infliximab therapy. Subsequently, several reports of probable infliximab hepatitis have been published and interest is growing in trying to elucidate the impact of these events on clinical practice. After discussing our case report, the main characteristics of infliximab-mediated liver injury are analyzed, coupled with a review of the medical literature. Infliximab seems to provoke both immunomediated and a direct liver injury, but how this latter happens remains unclear. Moreover, infliximab immunomediated liver dysfunction resembles that of autoimmune hepatitis type I, with elevation of antinuclear, anti-smooth muscle, anti-double-strand DNA antibodies, and a clear preference for female sex. Finally, a flow chart is proposed with the purpose to help clinicians in the management of patients who develop signs of liver dysfunction during treatment with infliximab.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Jan 13, 2001·Mayo Clinic Proceedings·V V Menghini, A S Arora
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Sep 2, 2003·Nature Reviews. Immunology·Bharat B Aggarwal
Sep 16, 2005·Annals of the Rheumatic Diseases·V GermanoG Valesini
Mar 21, 2006·Clinical Rheumatology·Gabriel J TobonJuan-Manuel Anaya
Mar 22, 2006·Clinical Rheumatology·Angel M García AparicioJuana Sampedro Alvarez
May 10, 2006·Clinical and Experimental Dermatology·S WahieN J Reynolds
May 31, 2006·Gastroenterología y hepatología·S Soto-FernándezF Ruiz-Carrillo
Aug 18, 2006·The New England Journal of Medicine·D L Scott, G H Kingsley
Oct 13, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Herbert TilgAlexander R Moschen
Nov 24, 2006·Internal and Emergency Medicine·Sergio Romagnani
Oct 12, 2007·Inflammatory Bowel Diseases·M MarquesC Costa Santos
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Jun 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elke M HennesUNKNOWN International Autoimmune Hepatitis Group
Aug 12, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Gérard ThiéfinJean-Paul Eschard
Sep 17, 2008·Clinical Rheumatology·Heidemarie BeckerMarkus Gaubitz
Oct 23, 2008·JAMA : the Journal of the American Medical Association·Thijs J GiezenAntoine C G Egberts
Mar 25, 2009·Clinical and Experimental Dermatology·D A Fairhurst, R Sheehan-Dare
May 30, 2009·Acta Dermato-venereologica·Nicolas KlugerDidier Bessis

❮ Previous
Next ❯

Citations

Dec 20, 2011·Current Gastroenterology Reports·John M Vierling
Dec 7, 2013·World Journal of Gastroenterology : WJG·Maurizio PompiliAntonio Grieco
Apr 8, 2014·Case Reports in Gastrointestinal Medicine·Ravish Parekh, Nirmal Kaur
Apr 27, 2012·Digestive Diseases and Sciences·Hilbert S de VriesDirk J de Jong
Mar 9, 2012·Journal of Crohn's & Colitis·Chiara van Casteren-MessidoroRob de Man
Nov 20, 2014·Future Medicinal Chemistry·Claire GinnSteve Brocchini
May 18, 2011·Journal of Crohn's & Colitis·Adam DoyleNick Kontorinis
May 7, 2013·Digestive Diseases and Sciences·Francisco ColinaPilar Martínez-Montiel
Dec 4, 2015·Expert Review of Gastroenterology & Hepatology·Jonathan G Stine, James H Lewis
Dec 23, 2011·Expert Opinion on Biological Therapy·Mauro ViganòMassimo Colombo
Apr 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·Jonathan G Stine, James H Lewis
Dec 23, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joshua B FrenchHerbert L Bonkovsky
Aug 22, 2015·The Journal of Infectious Diseases·Elaine Tennant, Jeffrey J Post
Jan 22, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Marwan GhabrilUNKNOWN US Drug-Induced Liver Injury Network
Jan 19, 2013·Annales de dermatologie et de vénéréologie·S CausséG Quéreux
Dec 14, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Andrea LisottiGiuseppe Mazzella
Sep 13, 2011·Clinics and Research in Hepatology and Gastroenterology·Daniel S SmykEirini I Rigopoulou
Sep 21, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Bradley W RoweJames A M Shapiro
May 9, 2013·The Australasian Journal of Dermatology·Lucy J DangJohn Su
Aug 19, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·John M Vierling
Feb 3, 2012·Immunopharmacology and Immunotoxicology·Giampiero GirolomoniGino Antonio Vena
Mar 10, 2015·Frontiers of Medicine·Farhad Sahebjam, John M Vierling
Jan 22, 2011·Hepatitis Research and Treatment·Kathleen M Gilbert
Jan 10, 2013·Cellular Immunology·Rodolfo ThoméWirla Maria da Silva Cunha Tamashiro
Jul 13, 2016·Expert Opinion on Drug Metabolism & Toxicology·Jonathan G Stine, Patrick G Northup
Nov 1, 2015·Journal of Medical Case Reports·Rogerio Serafim ParraOmar Feres
Oct 7, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Sophie RestelliniJean-Louis Frossard
Feb 3, 2016·Journal of Pediatric Gastroenterology and Nutrition·Shikib MostamandTamir Miloh
Jan 26, 2011·Nature Reviews. Rheumatology·Guruprasad P Aithal
Feb 1, 2019·European Journal of Gastroenterology & Hepatology·Waleed A Ismail, Ayman E Yousef
May 7, 2014·World Journal of Hepatology·Agustin CastiellaRaúl J Andrade
Dec 6, 2017·Nature Reviews. Urology·Arlene Siefker-Radtke, Brendan Curti
Jun 2, 2018·The Oncologist·Kerry ReynoldsMichael Dougan
Apr 1, 2011·Current Opinion in Gastroenterology·Marlyn J Mayo
May 6, 2011·Clinical Pharmacology and Therapeutics·G P AithalA K Daly
Nov 7, 2012·Therapeutic Drug Monitoring·Maria Grazia AnelliGiovanni Lapadula
Dec 18, 2014·World Journal of Gastroenterology : WJG·Roberta Elisa RossiCharles Daniel Murray
May 26, 2017·World Journal of Hepatology·My-Linh Tran-MinhJean-Marc Gornet
Mar 17, 2018·BioMed Research International·Marco FioreGiovanni Damiani
Dec 4, 2019·Clinical Case Reports·Frederick WongKarim Qumosani
Jul 4, 2015·World Journal of Gastroenterology : WJG·Susana RodriguesGuilherme Macedo
Feb 18, 2016·World Journal of Clinical Cases·Monica SalviAntonio Giovanni Richetta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.